Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

18.41

+0.25 (1.38%)

At close: May 22, 2026, 4:00 PM EDT

18.05

-0.36 (-1.96%)

After-hours: May 22, 2026, 7:22 PM EDT

Amphastar Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	170.94	170.18	151.61	144.3	156.1	126.35
Short-Term Investments	123.21	114.84	72.24	114.71	21.86	12.52
Cash & Short-Term Investments	294.15	285.01	223.85	259.01	177.96	138.87
Cash Growth	23.03%	27.33%	-13.58%	45.54%	28.15%	28.80%
Accounts Receivable	147.85	143.56	136.29	114.94	88.8	78.8
Other Receivables	9.61	17.17	1.75	0.53	0.17	0.13
Total Trade Receivables	157.45	160.73	138.04	115.47	88.98	78.93
Inventory	170.19	176.89	153.74	105.83	103.58	92.81
Other Current Assets	11.89	13.39	18.45	9.29	7.8	7.51
Total Current Assets	633.68	636.02	534.07	489.6	378.32	318.12
Net Property, Plant & Equipment	378.91	353.72	344.63	315.64	264.35	271.49
Goodwill	559.62	565.97	590.66	613.3	37.3	38.87
Long-Term Investments	-	-	11	15.21	2.41	3.99
Other Long-Term Assets	75.94	73.6	97.12	79.16	59.38	39.06
Total Assets	1,648	1,629	1,577	1,513	741.99	671.53
Accounts Payable	152.69	148.35	157.06	93.37	84.24	89.55
Accrued Expenses	-	-	-	126.09	-	-
Current Portion of Long-Term Debt	1.67	1.64	-	0.44	3.05	2.2
Current Portion of Leases	9.71	7.93	-	3.91	3	2.98
Other Current Liabilities	0.41	0.24	9.66	1.61	4.57	9.08
Total Current Liabilities	164.48	158.16	166.72	225.41	94.86	103.81
Long-Term Debt	609.8	608.75	-	589.58	72.84	74.78
Long-Term Leases	65.2	37.68	-	29.72	23.69	24.7
Other Long-Term Liabilities	35.29	35.91	-	28.78	21.93	22.72
Total Long-Term Liabilities	710.29	682.34	-	648.08	118.47	122.2
Total Liabilities	874.77	840.49	166.72	873.49	213.33	226.01
Common Stock	0.01	0.01	-	0.01	0.01	0.01
Treasury Stock	-438	-408.15	-	-247.43	-189.52	-150.48
Additional Paid-in Capital	543.82	535.38	-	486.06	455.08	422.42
Accumulated Other Comprehensive Income	-5.74	-5.31	-	-8.48	-8.62	-6.77
Retained Earnings	673.3	666.88	-	409.27	271.72	180.34
Total Common Shareholders' Equity	773.39	788.81	-	639.42	528.66	445.52
Shareholders' Equity	773.39	788.81	-	639.42	528.66	445.52
Total Liabilities & Equity	1,648	1,629	166.72	1,513	741.99	671.53
Total Debt	686.38	656	0	623.64	102.58	104.66
Net Cash (Debt)	-392.23	-370.99	223.85	-364.64	75.38	34.21
Net Cash Growth	-	-	-	-	120.34%	-15.63%
Net Cash Per Share	-8.28	-7.69	4.30	-6.88	1.44	0.69
Book Value	773.39	788.81	0	639.42	528.66	445.52
Book Value Per Share	16.33	16.36	-	12.06	10.08	8.95
Tangible Book Value	213.77	222.84	-590.66	26.13	491.36	406.65
Tangible Book Value Per Share	4.51	4.62	-11.35	0.49	9.37	8.17

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q